Navigation Links
Regulus Therapeutics Initiates an Orphan and Rare Disease microRNA Therapeutic Effort in Brain Cancer
Date:12/12/2011

LA JOLLA, Calif., Dec. 12, 2011 /PRNewswire/ -- Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the initiation of a new discovery effort in microRNA therapeutics for the treatment of glioblastoma multiforme (GBM), the most common and aggressive brain tumor in humans. Regulus will apply its expertise in microRNA therapeutics to discover chemically modified oligonucleotide anti-miRs for testing at the Samsung Medical Center in preclinical models that mimic human brain cancer. Accelerate Brain Cancer Cure (ABC2), a non-profit organization dedicated to accelerating therapies for brain cancer patients, has awarded Regulus a grant to support the research.

 

"GBM is a devastating disease with limited treatment options," said Neil W. Gibson, Ph.D. Chief Scientific Officer of Regulus Therapeutics. "At Regulus, we have successfully targeted microRNAs in multiple disease settings and believe that targeting dysregulated microRNAs using chemically modified oligonucleotide anti-miRs provides a potential therapeutic approach for GBM."

 

"A major hurdle in the discovery and development of novel therapeutics for GBM has been the lack of relevant animal models," said Do Hyun Nam, Ph.D. Professor and Director of Institute for Refractory Cancer Research, Samsung Medical Center. "In our collaboration with Regulus, we will utilize a recently developed model in which tumors derived from human patients are transplanted into mice resulting in a model directly relevant to human disease."

 

"Regulus has an impressive track record of executing on innovation in the field of microRNA therapeutics," said Max Wallace, Chief Executive Officer, ABC2. "The combination of Regulus' expertise in microRNA therapeutics with Samsung's preclinical GBM models compelled us to support this pr
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
3. Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
4. Webinar Advisory: Regulus to Host Discussion About Potential of microRNA-33 as Target for Treatment of Atherosclerosis
5. Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Atossa Genetics, Inc. (NASDAQ: ... that Kyle Guse , Chief Financial Officer ... LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hotel. The Company,s presentation is scheduled to ... a live webcast. To access the webcast, go to ...
(Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare International, ... leading innovator of less invasive, miniaturized circulatory support technologies that ... that CEO Doug Godshall is scheduled ... 11:00 a.m. EDT on Monday, May 20, 2013.  The conference ... York Hotel. A live webcast of the Company,s ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... Adeona Pharmaceuticals, Inc., (AMEX: AEN ) announced ... on Tuesday, November 2, from 9 a.m. to 10 a.m., ... MI, 48108. During the Annual Shareholder Meeting, ... give an update on the Company,s activities and answer questions. ...
... Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that ... Conference in New York on November 2, 2010 at 11:25 ... Annual Healthcare Conference in New York on November 17, 2010 ... be webcast live and may be accessed through a link ...
Cached Medicine Technology:Gen-Probe to Webcast Two Upcoming Investor Presentations 2
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn ... help people get in shape, and gain a healthy life ... also is a natural fat loss system that provides people ... this fat loss diet program claimed that The Fat Loss ... keep body fat off long-term. After Shawn Stevenson launched this ...
(Date:5/19/2013)... Exciting new Skin Brushes are available ... great practice known through the ages but is a ... body brushing, has so many benefits for our health ... "We love that circulation and lymphatic systems get a ... skin, is supported through Skin Brushing." , Why is ...
(Date:5/19/2013)... GA (PRWEB) May 19, 2013 The AMTC ... 2pm at the Columbus Georgia Convention & Trade Center on ... invited to attend. AMTC auditions are free of charge. , ... starting point for hundreds of successful artists and grads like ... face for European Tombolini , Chris Young - on his ...
(Date:5/19/2013)... 19, 2013 The Da Vinci robot ... developments in the nation’s first trial involving a Da ... Washington State Superior Court, was filed by the widow ... suffered complications in a robot-assisted prostate removal, according to ... Vinci robotic surgery lawsuit alleges those complication’s hastened ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... and MTA: CTIC) announced today that it has rescheduled the ... Tuesday, March 24, 2009, in order to allow additional time ... on or about February 12, 2009, to be adequately disseminated ... receive at least 20 days written notice of the special ...
... Corporation (NYSE: ORI ) announced today ... regular quarterly cash dividend of 17 cents per common share. ... shareholders of record on March 4, 2009.The latest cash dividend ... the second quarter of 2008. The rate reflects the ...
... Funding Plan Improves Access, Modernizes TechnologyWASHINGTON, Feb. 26 ... Department of Veterans Affairs (VA) expands eligibility for ... over the next five years, meets the need ... Veterans of Iraq and Afghanistan and provides the ...
... Institute for Virology and Immunology Center for AIDS Research ... next generation of HIV/AIDS researchers and clinician scientists. ... American Journal for Public Health appearing February ... website, the program focuses on overcoming challenges faced by ...
... HARRISBURG, Pa., Feb. 26 Dean Farms in New ... contamination and resumed sales of raw milk on ... Raw milk is milk that has not been pasteurized. ... have samples of their milk laboratory tested due to ...
... The following is a statement from Georges ... of the American Public Health Association:"The American Public ... members of Congress and families across the nation ... to health reform."Along with the continued emphasis on ...
Cached Medicine News:Health News:Cell Therapeutics Reschedules Special Meeting 2Health News:Cell Therapeutics Reschedules Special Meeting 3Health News:President's 2010 Budget Request Strongly Supports VA Programs 2Health News:Effective mentoring critical to HIV/AIDS research efforts 2Health News:Lawrence County Raw Milk Dairy Tests Negative For Campylobacter; Raw Milk Sales Resumed 2
... The Netmon remote monitoring service allows ... programmed and monitored from any location ... The service enhances preventive maintenance capabilities. ... access the unit (with your permission) ...
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...
The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens....
Medicine Products: